Hybrid ablation (HA) combines the strengths of thoracoscopic surgical ablation and catheter-based endocardial ablation in a single treatment strategy.
Performed either as a single-stage or two-stage procedure, hybrid ablation allows clinicians to both create and validate lesions within the same pathway of care.
In a single-stage procedure, intraoperative electrophysiological mapping confirms the completeness of surgical lesions in real time. Any gaps can be immediately identified and treated, ensuring effective isolation. The left atrial appendage is also routinely closed as part of the procedure.
This collaborative approach enables a comprehensive treatment without the need for sternotomy or cardiopulmonary bypass.
Hy⁵ combines surgical ablation and electrophysiological validation into a single, coordinated pathway.
From pulmonary vein isolation through to ongoing monitoring, each step is designed to create, confirm and maintain durable lesions — reducing variability and improving consistency of outcomes.
No single approach can fully address complex atrial fibrillation.
By combining surgical access with electrophysiological insight, CS/EP collaboration enables more complete treatment — reducing the need for repeat procedures and improving the likelihood of durable success.
3-7x
2x
73-80%
“When electrophysiologists and cardiac surgeons collaborate effectively, patient outcomes are significantly improved and more durable.”
Dr M. Wehbe discusses the patient profile for the Hy⁵ procedure.
There are six Hy⁵ centers throughout Germany that treat this patient population using the Hy⁵ collaborative approach, within the heart team.
Refer your patient here